Literature DB >> 23357128

Inflammation and atherosclerosis: direct versus indirect mechanisms.

Michael E Rosenfeld1.   

Abstract

It is now widely accepted that the development of atherosclerotic lesions involves a chronic inflammatory response that includes both innate and adaptive immune mechanisms. However, it is still unclear precisely what induces the inflammatory response. Furthermore, inflammation within the blood vessel can be divided into direct mechanisms where the primary inflammatory events occur within the intima of the blood vessel and contribute to both the initiation and progression of the plaques and indirect mechanisms where inflammation at nonvascular sites can contribute to the progression of the lesions. The direct mechanisms include lipid deposition and modification, influx of lipoprotein associated factors and microparticles derived from many different cell types, and possibly bacterial and viral infection of vascular cells. Indirect mechanisms derive from inflammation related to autoimmune diseases, smoking, respiratory infection, and pollution exposure, and possibly periodontal disease and gastric infection. The mechanisms include secretion of cytokines and other inflammatory factors into the circulation with subsequent uptake into the plaques, egress and recruitment of activated inflammatory cells, formation of dysfunctional HDL and crossreactive autoantibodies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23357128      PMCID: PMC3654071          DOI: 10.1016/j.coph.2013.01.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  88 in total

Review 1.  The role of innate immunity in atherogenesis.

Authors:  Karsten Hartvigsen; Meng-Yun Chou; Lotte F Hansen; Peter X Shaw; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

Review 2.  Myeloid cells in atherosclerosis: initiators and decision shapers.

Authors:  Oliver Soehnlein; Christian Weber
Journal:  Semin Immunopathol       Date:  2009-02-24       Impact factor: 9.623

Review 3.  Cell-derived microparticles in haemostasis and vascular medicine.

Authors:  Laurent Burnier; Pierre Fontana; Brenda R Kwak; Anne Angelillo-Scherrer
Journal:  Thromb Haemost       Date:  2009-03       Impact factor: 5.249

Review 4.  Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis.

Authors:  Filip K Swirski; Ralph Weissleder; Mikael J Pittet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-16       Impact factor: 8.311

5.  Identification of splenic reservoir monocytes and their deployment to inflammatory sites.

Authors:  Filip K Swirski; Matthias Nahrendorf; Martin Etzrodt; Moritz Wildgruber; Virna Cortez-Retamozo; Peter Panizzi; Jose-Luiz Figueiredo; Rainer H Kohler; Aleksey Chudnovskiy; Peter Waterman; Elena Aikawa; Thorsten R Mempel; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

6.  Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

Authors:  W Sean Davidson; R A Gangani D Silva; Sandrine Chantepie; William R Lagor; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

7.  CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.

Authors:  René R S Packard; Elena Maganto-García; Israel Gotsman; Ira Tabas; Peter Libby; Andrew H Lichtman
Journal:  Circ Res       Date:  2008-10-02       Impact factor: 17.367

8.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

Authors:  Meng-Yun Chou; Linda Fogelstrand; Karsten Hartvigsen; Lotte F Hansen; Douglas Woelkers; Peter X Shaw; Jeomil Choi; Thomas Perkmann; Fredrik Bäckhed; Yury I Miller; Sohvi Hörkkö; Maripat Corr; Joseph L Witztum; Christoph J Binder
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

Review 9.  The role of a murine transplantation model of atherosclerosis regression in drug discovery.

Authors:  Jonathan E Feig; John S Quick; Edward A Fisher
Journal:  Curr Opin Investig Drugs       Date:  2009-03

10.  TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Authors:  Yoshikazu Naiki; Rosalinda Sorrentino; Michelle H Wong; Kathrin S Michelsen; Kenichi Shimada; Shuang Chen; Atilla Yilmaz; Anatoly Slepenkin; Nicolas W J Schröder; Timothy R Crother; Yonca Bulut; Terence M Doherty; Michelle Bradley; Zory Shaposhnik; Ellena M Peterson; Peter Tontonoz; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more
  24 in total

1.  Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.

Authors:  I M Quesada; A Lucero; C Amaya; D N Meijles; M E Cifuentes; P J Pagano; C Castro
Journal:  Atherosclerosis       Date:  2015-08-08       Impact factor: 5.162

2.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  Leucine-nicotinic acid synergy stimulates AMPK/Sirt1 signaling and regulates lipid metabolism and lifespan in Caenorhabditis elegans, and hyperlipidemia and atherosclerosis in mice.

Authors:  Antje Bruckbauer; Jheelam Banerjee; Quiang Cao; Xin Cui; Jia Jing; Lin Zha; Fenfen Li; Bingzhong Xue; Hang Shi; Michael B Zemel
Journal:  Am J Cardiovasc Dis       Date:  2017-04-15

4.  Placental lesions associated with acute atherosis.

Authors:  Yeon Mee Kim; Piya Chaemsaithong; Roberto Romero; Majid Shaman; Chong Jai Kim; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Ahmed I Ahmed; Tinnakorn Chaiworapongsa; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-30

5.  Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.

Authors:  Prakash Doddapattar; Chintan Gandhi; Prem Prakash; Nirav Dhanesha; Isabella M Grumbach; Michael E Dailey; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-01       Impact factor: 8.311

Review 6.  Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.

Authors:  Jordan S Pober; Dan Jane-wit; Lingfeng Qin; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-05       Impact factor: 8.311

7.  The effect of disease control on mean platelet volume and red blood cell distribution in patients with acromegaly.

Authors:  Rifki Ucler; Mehmet Aslan; Murat Atmaca; Murat Alay; Esra Nur Ademoglu; Zehra Candan; Ismail Gulsen
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 8.  Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.

Authors:  Elin Org; Margarete Mehrabian; Aldons J Lusis
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

Review 9.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

10.  Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway.

Authors:  Yu Fu; Dandan Ma; Yue Liu; Hui Li; Jinyu Chi; Wenxiu Liu; Fang Lin; Jing Hu; Xiaohui Zhang; Minling Zhu; Yong Zhao; Xinhua Yin
Journal:  Lab Invest       Date:  2015-08-24       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.